Friday
11.15.2019
10:46 AM
Login form
Search
Calendar
«  October 2012  »
SuMoTuWeThFrSa
 123456
78910111213
14151617181920
21222324252627
28293031
Entries archive

My site

Main » 2012 » October » 27
The European Commission has approved expanded indication for linagliptin in a wider range of adult Type 2 Diabetes (T2D) patients

INGELHEIM, Germany - Friday, October 26th 2012 [ME NewsWire]

(BUSINESS WIRE)-- For Non-U.S. and Non-U.K. Media

Boehringer Ingelheim and Eli Lilly and Companytoday announced that the European Commission has approved an expanded therapeutic indication for the DPP-4 inhibitor Trajenta® (linagliptin) to include use in combination with insulin in adults with Type 2 Diabetes.

"We are delighted that approval has been granted for the use of linagliptin as an add-on to insulin in adults with Type 2 Diabetes,” said Prof. Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim, "This expanded indication shows that linagliptin is an effective treatment for patients at various stages of Type 2 Diabetes.”

The approval means linagliptin is now indicated for use in combination with insulin with or without metformin, ... Read more »
Views: 138 | Added by: africa-live | Date: 10.27.2012